Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Share News (IQAI)

Share Price Information for IQ-AI (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.20 (16.667%)
Open: 1.30
High: 1.40
Low: 1.30
Prev. Close: 1.30
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IQ-AI's Imaging Biometrics signs Korea distribution deal

Wed, 28th Nov 2018 12:05

(Sharecast News) - IQ-AI announced on Wednesday that its subsidiary Imaging Biometrics has appointed Korea Motion as its first distributor in South East Asia.The London-listed firm said Korean Motion would sell IB's full range of diagnostic imaging products in the areas of brain tumour detection, using perfusion maps and the monitoring of brain tumour development.It said the products had been presented to several "leading South Korean hospitals" over the last few months, generating "significant" potential sales interest."Our South Korean partner recently demonstrated their enthusiasm and competence in the medical software field through the introduction of 'StoneChecker', securing the first commercial order for that product earlier this month," said Imaging Biometrics chief executive officer David Smith."After trialing the full Imaging Biometrics range with several hospitals in recent months we are confident they will repeat this success with our products for detecting and monitoring brain tumors."This latest agreement marks the start of a concerted effort by management to develop global markets for Imaging Biometrics' products, building upon the success we are achieving in the United States."Additionally, IQ-AI said Imaging Biometrics had received ISO 13485:2016 certification for 'Medical Device and Quality Management Systems'.It said the ISO certification was required for regulatory purposes specific to the medical device industry, with the specific standard supporting the design, development, manufacture, and distribution of medical devices.To be certified, IQ-AI said companies needed demonstrate their ability to provide medical devices and services that consistently fulfilled customer and regulatory requirements."This certification underscores our company's steadfast commitment of providing high-quality products to our clients," said David Smith."Maintaining a world-class quality management system is a key goal of IB, and our clients can feel confident that our quality management system provides a solid framework for how we conduct business."
More News
22 Oct 2018 11:41

IQ-AI Files Patent For Gadolinium-Free MRI Brain Scan Technology

LONDON (Alliance News) - IQ-AI Ltd, formerly known as Flying Brands Ltd, said Monday it has filed a patent for a type of magnetic resonance imaging that does not use gadolinium contrast in IQ-AI a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.